LB
TMO icon

Legacy Bridge’s Thermo Fisher Scientific TMO Stock Holding History

Legacy Bridge’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
2,115
-37
-2% -$20.1K 0.4% 83
2025
Q4 		$1.25M Hold
2,152
– – 0.51% 70
2025
Q3 		$1.04M Sell
2,152
-34
-2% -$15.8K 0.43% 76
2025
Q2 		$886K Sell
2,186
-64
-3% -$26.8K 0.42% 78
2025
Q1 		$1.12M Buy
2,250
+121
+6% +$65.5K 0.62% 64
2024
Q4 		$1.11M Sell
2,129
-8
-0.4% -$4.4K 0.58% 71
2024
Q3 		$1.32M Sell
2,137
-6
-0.3% -$3.55K 0.71% 57
2024
Q2 		$1.19M Sell
2,143
-10
-0.5% -$5.73K 0.7% 60
2024
Q1 		$1.25M Sell
2,153
-11
-0.5% -$6.17K 0.73% 61
2023
Q4 		$1.15M Sell
2,164
-42
-2% -$20.3K 0.74% 62
2023
Q3 		$1.12M Hold
2,206
– – 0.8% 50
2023
Q2 		$1.15M Buy
2,206
+67
+3% +$36.2K 0.77% 50
2023
Q1 		$1.23M Hold
2,139
– – 0.86% 44
2022
Q4 		$1.18M Buy
2,139
+91
+4% +$48.2K 0.84% 44
2022
Q3 		$1.04M Hold
2,048
– – 0.83% 51
2022
Q2 		$1.11M Hold
2,048
– – 0.82% 43
2022
Q1 		$1.21M Sell
2,048
-511
-20% -$294K 0.71% 55
2021
Q4 		$1.71M Sell
2,559
-33
-1% -$20.6K 0.89% 33
2021
Q3 		$1.48M Buy
2,592
+50
+2% +$27.4K 0.85% 33
2021
Q2 		$1.28M Sell
2,542
-57
-2% -$26.9K 0.73% 48
2021
Q1 		$1.19M Buy
2,599
+250
+11% +$119K 0.77% 50
2020
Q4 		$1.09M Buy
2,349
+53
+2% +$24.9K 0.79% 44
2020
Q3 		$1.01M Hold
2,296
– – 0.93% 32
2020
Q2 		$832K Sell
2,296
-868
-27% -$291K 0.92% 33
2020
Q1 		$897K Sell
3,164
-65
-2% -$20.5K 1.13% 18
2019
Q4 		$1.05M Buy
3,229
+227
+8% +$68.8K 0.87% 28
2019
Q3 		$874K Sell
3,002
-108
-3% -$30.9K 0.83% 33
2019
Q2 		$913K Buy
3,110
+12
+0.4% +$3.31K 0.88% 25
2019
Q1 		$848K Buy
3,098
+60
+2% +$14.9K 0.87% 27
2018
Q4 		$680K Buy
+3,038
New +$713K 0.84% 32

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Legacy Bridge's TMO Position: Q1 2026 in Review

Legacy Bridge reduced its Thermo Fisher Scientific (TMO) stake by 1.7% in Q1 2026, selling an estimated $20.1K and leaving 2,115 shares worth $1.04M. The position accounts for 0.4% of the portfolio, ranked #83.

Legacy Bridge first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.71M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Legacy Bridge held 2,115 shares of Thermo Fisher Scientific worth $1.04M as of Q1 2026.
  • Legacy Bridge sold 37 Thermo Fisher Scientific shares in Q1 2026, an estimated $20.1K.
  • Thermo Fisher Scientific made up 0.4% of Legacy Bridge's portfolio in Q1 2026, its #83 holding.
  • Legacy Bridge first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Legacy Bridge's Thermo Fisher Scientific position peaked at $1.71M in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.